Like I said, we share different opinions. I see lo

Like I said, we share different opinions. I see lots of value in a growing company, even more so at this price point.

What about this July 8th Press Release regarding "Praxsyn's 2015 Anticipated Business Strategies" ?

Quote:

---

Praxsyn Corporation's (OTCQB: PXYN) anticipated business plan for 2015 is to acquire a sister subsidiary retail community pharmacy and to purchase additional pharmacies. Mesa is also in the early stages of developing a program to supply medications and products to diabetic patients and anticipates the commencement of filling prescriptions by the end of the third quarter of 2015.

By expanding the number of pharmacies, Praxsyn believes they will be able to diversify and enlarge their range of products and their field of operations. The plans for a pharmacy acquisition, as well as the expansion into diabetic medications and products, fits with Praxsyn's business strategy of further diversifying their product lines as well as building and acquiring regional pharmacies.

"We are making key, target moves as we continue to grow our company, one of which is to be of service to patients who are suffering with diabetes," said Edward Kurtz, CEO of Praxsyn Corporation. "We plan to offer a variety of therapeutic products that meet the needs of diabetic patients."

---

Growth like that requires money.